Table 2.
(A) | ||
---|---|---|
Copy # | RT‐iiPCR Results (#positive/total) | R1 (Average ± SD) |
100 000 | 5/5 | 4.81 ± 0.12 |
10 000 | 5/5 | 4.69 ± 0.12 |
1000 | 5/5 | 4.68 ± 0.08 |
100 | 6/6 | 4.62 ± 0.31 |
50 | 7/7 | 4.10 ± 0.80 |
20 | 5/5 | 4.36 ± 0.73 |
5 | 2/6 | 2.87 ± 2.05 |
0 | 0/7 | 0.99 ± 0.04 |
(B) | ||||
---|---|---|---|---|
FMDV | RT‐iiPCR | RRT‐PCR | ||
Isolate (Serotype) | Dilution | Result | R1 | CT |
A22/IRQ/24/64 (A) | 10−5 | + | 4.96 | 34.91 |
10−6 | + | 4.94 | 39.53 | |
10−7 | − | 1.00 | No CT | |
O/UKG/11/2001 (O) | 10−6 | + | 4.92 | 28.01 |
10−7 | + | 4.77 | 31.84 | |
10−8 | − | 1.03 | 38.13 | |
C1/Noville (C) | 10−7 | + | 4.97 | 33.81 |
10−8 | + | 4.94 | No CT | |
10−9 | − | 1 | No CT | |
Asia 1/Shamir (Asia) | 10−4 | + | 4.86 | 34.61 |
10−5 | + | 4.95 | No CT | |
10−6 | − | 0.98 | No CT | |
SAT1/KEN/4/98 (SAT1) | 10−7 | + | 4.97 | 31.55 |
10−8 | + | 4.8 | 35.83 | |
10−9 | − | 1.09 | No CT | |
SAT2/SAU/1/2000 (SAT2) | 10−6 | + | 4.95 | 32.08 |
10−7 | + | 4.84 | 38.73 | |
10−8 | − | 0.99 | No CT | |
SAT3/ZIM/4/81 (SAT3) | 10−7 | + | 4.91 | 34.61 |
10−8 | + | 4.93 | No CT | |
10−9 | − | 0.97 | No CT |
(A) Using in vitro‐transcribed (IVT) FMDV O1 Manisa/69 3D RNA. The IVT RNA was serially diluted in nuclease‐free water, and 5 μl of each dilution was tested in RT‐iiPCR assay. The assay was repeated a minimum of 5 times. (B) Using FMD viral RNA representing all 7 serotypes. R1 = R1 (signal/noise ratio) value. SD = standard deviation. In RRT‐PCR assay, a sample was considered positive when the threshold cycle (CT) value was lower than 36. UKG = Channel Islands, ZIM = Zimbabwe.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.